GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » COSMOS Pharmaceutical Corp (TSE:3349) » Definitions » 3-Year Revenue Growth Rate

COSMOS Pharmaceutical (TSE:3349) 3-Year Revenue Growth Rate

: 6.50% (As of Nov. 2023)
View and export this data going back to 2004. Start your Free Trial

COSMOS Pharmaceutical's Revenue per Share for the three months ended in Nov. 2023 was 円5,925.27.

During the past 12 months, COSMOS Pharmaceutical's average Revenue per Share Growth Rate was 14.20% per year. During the past 3 years, the average Revenue per Share Growth Rate was 6.50% per year. During the past 5 years, the average Revenue per Share Growth Rate was 7.90% per year. During the past 10 years, the average Revenue per Share Growth Rate was 9.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 13 years, the highest 3-Year average Revenue per Share Growth Rate of COSMOS Pharmaceutical was 18.10% per year. The lowest was -7.80% per year. And the median was 11.00% per year.


Competitive Comparison

For the Pharmaceutical Retailers subindustry, COSMOS Pharmaceutical's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


COSMOS Pharmaceutical 3-Year Revenue Growth Rate Distribution

For the Healthcare Providers & Services industry and Healthcare sector, COSMOS Pharmaceutical's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where COSMOS Pharmaceutical's 3-Year Revenue Growth Rate falls into.



COSMOS Pharmaceutical 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.


COSMOS Pharmaceutical  (TSE:3349) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.


COSMOS Pharmaceutical 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of COSMOS Pharmaceutical's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


COSMOS Pharmaceutical (TSE:3349) Business Description

Traded in Other Exchanges
N/A
Address
4 floor,10th first Fukuoka S Building Museum, Hakataekihigashi 2-chome,, Fukuoka, JPN, 812-0013
COSMOS Pharmaceutical Corp manages retail drugstores in Japan. The company places a strong emphasis on convenience regarding its product selection, which includes medical products, health and beauty aids, personal-care items, discount cosmetics, household items, food and beverages, greeting cards, seasonal merchandise, alcoholic beverages, tobacco, insect repellent, and miscellaneous everyday consumables. The majority of the company's revenue is derived from common grocery sales. Cosmos also operates a private grocery brand called ON 365.

COSMOS Pharmaceutical (TSE:3349) Headlines

No Headlines